<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To analyze the clinical and cytogenetic features of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>(<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) associated with del(20q) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: The cytogenetic profiles, clinical manifestations, laboratory data, and transformation in course of disease were analyzed </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: (1) Of 29 MDS patients with del(20q), eleven (37.9%) had <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype in addition to del(20q) aberration </plain></SENT>
<SENT sid="3" pm="."><plain>Among them, nine patients were categorized into <z:hpo ids='HP_0005505'>refractory anemia</z:hpo>(RA)/RA with ringed sideroblasts(<z:mp ids='MP_0011356'>RAS</z:mp>) group and two into RA with excess Hasts(<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>)/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> in transformation(<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB-T</z:e>) group </plain></SENT>
<SENT sid="4" pm="."><plain>The breakpoint in 20q11 was commonly seen in patients with RA/<z:mp ids='MP_0011356'>RAS</z:mp>(63.2%), while del(20q12) was predominant in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB-T</z:e>(accounting for 70% in <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB-T</z:e> patients) </plain></SENT>
<SENT sid="5" pm="."><plain>It was observed that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB-T</z:e> patients had higher frequencies of extra chromosomal aberrations(50%) and complex karyotype(30%) than did the RA/<z:mp ids='MP_0011356'>RAS</z:mp> patients (26.3%, 5.3% respectively); (2) Almost <z:hpo ids='HP_0000001'>all</z:hpo> patients revealed prominent <z:hpo ids='HP_0001876'>pancytopenia</z:hpo>, dyserythropoiesis and dysgranulopoiesis and 58.6% patients showed dysmegakaryopoiesis; positive <z:chebi fb="0" ids="29149">periodic acid</z:chebi> schiff staining of nucleated erythrocytes or reduction of neutrophils were found in 62.5% of patients; 81.8% of patients expressed lymphoid antigens; (3) Two cases transformed to <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: Del(20q) may be an early and primary cytogenetic event in the development of <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0001876'>Pancytopenia</z:hpo> and <z:mpath ids='MPATH_589'>dysplasia</z:mpath> of bone marrow cells are prominent in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> associated with del(20q); lymphoid antigen expression is a common occurrence; more additional chromosomal abnormalities and complex karyotypes appear when the disease becomes worse </plain></SENT>
</text></document>